Added successfully to RFQ list

Added successfully to compare list

Power Your Pipeline With India

Excellence for accelerated drug discovery

Why is India the Perfect Destination for Your Next Drug Discovery Project?

India's CRO landscape is evolving rapidly, with clinical development services taking the lead, followed by discovery chemical services. To stay ahead of shifting regulatory landscapes, CROs are enhancing their scientific writing and regulatory capabilities. Notably, biomarker development and companion diagnostics are emerging as critical areas of focus, particularly in the context of precision medicine and targeted therapies.

Therapeutic area trends reflect growing demand for CRO support in oncology, respiratory diseases, rare diseases, infectious diseases, CNS disorders, and immunology. Advances in genomics, the rise of precision medicine, and advocacy from patient groups are driving the need for specialised trials in these areas. As regulatory complexities increase and markets globalize, Indian CROs are expanding their capabilities and geographic reach to meet this demand, making them a crucial player in the future of drug discovery and development.

The Strategic Edge of Partnering with India

detail-icon

Scientific Talent Pool

A vast pool of highly skilled scientists with expertise in cutting-edge technologies

detail-icon

Secure and Reliable

Strong IP protection, privacy measures, and robust compliance with global regulatory standards

detail-icon

Advanced Infrastructure

Modern research facilities equipped to handle complex discovery needs

detail-icon

Fast Supply Chain

Fast and reliable supply chain to accelerate project timelines and deliverables

detail-icon

Favourable Policies

Supportive biotech and outsourcing regulations that promote innovation and partnership

Key Stats

10.75%

(approx.)

CAGR growth will push India's CRO sector to USD 2.5 billion  tooltip-icon

$82M+

(approx.)

infrastructure for drug discovery and development  tooltip-icon

$2M+

(approx.)

to develop common facilities such as testing labs and effluent treatment plants  tooltip-icon

border-icon

About o2h discovery

Founded in 2005, o2h discovery has a multi-modality integrated drug discovery platform, operating from Ahmedabad, India, and Cambridge, UK. We have the in-house capability to execute hit-lead-optimization programs leading into patent and IND filing with expertise in discovery chemistry, biology, pharmacology, and the ongoing project management of pre-clinical development.

o2h has acquired an 80,000 sq. ft. site, with a cutting-edge R&D centre nearing completion, designed to accommodate over 750 scientists specialising in preclinical drug discovery. Currently, the building is operational, housing around 400-450 chemistry fume hoods, state-of-the-art scale-up and process research facilities, and in-vitro ADME, biology capabilities. With a proven track record of working with “me too” and “undruggable” class of targets and a deep understanding of potency to efficacy translational, we provide an integrated suite of high-quality biophysical, biochemical & cellular-assay platforms.